Cargando…

Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors

PURPOSE: Social stigma related to coronavirus disease-2019 (COVID-19) has been a public concern since its emergence, especially in the patients who are reintegrating into their society. However, the insights into COVID-19 stigmatization after vaccine availability are limited. This study aimed to est...

Descripción completa

Detalles Bibliográficos
Autores principales: Techapoonpon, Kamolvisa, Kerdchareon, Nitchawan, Polruamngern, Nongnuch, Chalermrungroj, Teeraphan, Srikhamdokkhae, Orranee, Matangkarat, Premyuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478950/
https://www.ncbi.nlm.nih.gov/pubmed/37675190
http://dx.doi.org/10.2147/PRBM.S425537
_version_ 1785101460755709952
author Techapoonpon, Kamolvisa
Kerdchareon, Nitchawan
Polruamngern, Nongnuch
Chalermrungroj, Teeraphan
Srikhamdokkhae, Orranee
Matangkarat, Premyuda
author_facet Techapoonpon, Kamolvisa
Kerdchareon, Nitchawan
Polruamngern, Nongnuch
Chalermrungroj, Teeraphan
Srikhamdokkhae, Orranee
Matangkarat, Premyuda
author_sort Techapoonpon, Kamolvisa
collection PubMed
description PURPOSE: Social stigma related to coronavirus disease-2019 (COVID-19) has been a public concern since its emergence, especially in the patients who are reintegrating into their society. However, the insights into COVID-19 stigmatization after vaccine availability are limited. This study aimed to estimate the prevalence, severity and associated factors of stigma experienced by patients who recovered from COVID-19 and reintegrated into their communities. The insights gained from this study are not only beneficial to COVID-19 but can also be used as a background information in future epidemics. PATIENTS AND METHODS: This study consisted of two phases. The first phase involved the translation and validation of the COVID-19-related stigma questionnaire. The second phase was a questionnaire-based cross-sectional survey conducted between January and February 2022, at the Vajira Hospital, Bangkok, Thailand. A series of questionnaires regarding stigma, negative emotions (Depression Anxiety Stress Scale-21), and personal information were administered to COVID-19 patients who were already discharged and returned to their communities from June 2021 to February 28, 2022 (N = 354). RESULTS: The prevalence of stigma among the patients who recovered from COVID-19 was 57.9%. These were classified as mild (28.2%), moderate (21.5%), and severe (8.2%). Pearson’s correlation analysis revealed that longer admissions (r = - 0.151, p = 0.001) and longer duration from discharge (r = - 0.222, p = 0.001) were related to lower stigma. Higher stigma was associated with higher levels of depression (r = 0.528, p <0.001), anxiety (r = 0.506, p <0.001) and stress (r = 0.583, p <0.001). CONCLUSION: Social stigma related to COVID-19 in Thailand declined during the post-vaccination period. However, this issue did not disappear, and still took a toll on mental health. Our findings suggested that providing appropriate assessment and help to the patients who recovered from COVID-19 is essential, even in the post-vaccination period.
format Online
Article
Text
id pubmed-10478950
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104789502023-09-06 Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors Techapoonpon, Kamolvisa Kerdchareon, Nitchawan Polruamngern, Nongnuch Chalermrungroj, Teeraphan Srikhamdokkhae, Orranee Matangkarat, Premyuda Psychol Res Behav Manag Original Research PURPOSE: Social stigma related to coronavirus disease-2019 (COVID-19) has been a public concern since its emergence, especially in the patients who are reintegrating into their society. However, the insights into COVID-19 stigmatization after vaccine availability are limited. This study aimed to estimate the prevalence, severity and associated factors of stigma experienced by patients who recovered from COVID-19 and reintegrated into their communities. The insights gained from this study are not only beneficial to COVID-19 but can also be used as a background information in future epidemics. PATIENTS AND METHODS: This study consisted of two phases. The first phase involved the translation and validation of the COVID-19-related stigma questionnaire. The second phase was a questionnaire-based cross-sectional survey conducted between January and February 2022, at the Vajira Hospital, Bangkok, Thailand. A series of questionnaires regarding stigma, negative emotions (Depression Anxiety Stress Scale-21), and personal information were administered to COVID-19 patients who were already discharged and returned to their communities from June 2021 to February 28, 2022 (N = 354). RESULTS: The prevalence of stigma among the patients who recovered from COVID-19 was 57.9%. These were classified as mild (28.2%), moderate (21.5%), and severe (8.2%). Pearson’s correlation analysis revealed that longer admissions (r = - 0.151, p = 0.001) and longer duration from discharge (r = - 0.222, p = 0.001) were related to lower stigma. Higher stigma was associated with higher levels of depression (r = 0.528, p <0.001), anxiety (r = 0.506, p <0.001) and stress (r = 0.583, p <0.001). CONCLUSION: Social stigma related to COVID-19 in Thailand declined during the post-vaccination period. However, this issue did not disappear, and still took a toll on mental health. Our findings suggested that providing appropriate assessment and help to the patients who recovered from COVID-19 is essential, even in the post-vaccination period. Dove 2023-09-01 /pmc/articles/PMC10478950/ /pubmed/37675190 http://dx.doi.org/10.2147/PRBM.S425537 Text en © 2023 Techapoonpon et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Techapoonpon, Kamolvisa
Kerdchareon, Nitchawan
Polruamngern, Nongnuch
Chalermrungroj, Teeraphan
Srikhamdokkhae, Orranee
Matangkarat, Premyuda
Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors
title Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors
title_full Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors
title_fullStr Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors
title_full_unstemmed Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors
title_short Stigma Experienced by Patients Who Recovered from COVID-19 in Post-Vaccination Period in Thailand; Prevalence and Associated Factors
title_sort stigma experienced by patients who recovered from covid-19 in post-vaccination period in thailand; prevalence and associated factors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478950/
https://www.ncbi.nlm.nih.gov/pubmed/37675190
http://dx.doi.org/10.2147/PRBM.S425537
work_keys_str_mv AT techapoonponkamolvisa stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors
AT kerdchareonnitchawan stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors
AT polruamngernnongnuch stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors
AT chalermrungrojteeraphan stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors
AT srikhamdokkhaeorranee stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors
AT matangkaratpremyuda stigmaexperiencedbypatientswhorecoveredfromcovid19inpostvaccinationperiodinthailandprevalenceandassociatedfactors